Skip to Main Content

Author Details

Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
2018
19
14
PMIDPaper TitleJournal TitlePublished Year
37828555Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.Genome Med2023
38023254Fanconi anemia pathway regulation by FANCI in prostate cancer.Front Oncol2023
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
33420073Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.Nat Commun2021
33836265Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial.Ann Oncol2021
34489465Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.Nat Commun2021
34348967Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.Cancer Res2021
34337548Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.Eur Urol Open Sci2021
34283056Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.Cancers (Basel)2021
34083234Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.Clin Cancer Res2021
32451180Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.Eur Urol2020
31744831Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.Clin Cancer Res2020
33033260Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.Nat Commun2020
32574722HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies.Ann Oncol2020
32914020Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer.JCO Precis Oncol2019
31727538Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.Lancet Oncol2019
29367197Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.Cancer Discov2018
30272002Frequent mutation of the <i>FOXA1</i> untranslated region in prostate cancer.Commun Biol2018
29985419Interleukin 10 mutant zebrafish have an enhanced interferon gamma response and improved survival against a Mycobacterium marinum infection.Sci Rep2018
  • 1 - 19 of 19

Recommended Authors

Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Career Start Year 2017
Number of shared co-authors 3
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 11
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 3
Edward O'Connor
Dana-Farber Cancer Institute
Career Start Year 2017
Number of shared co-authors 4
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 3
Lisanne F van Dessel
Erasmus MC Cancer Institute
Career Start Year 2015
Number of shared co-authors 3
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 5
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 4
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 5
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 2
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 11
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 1
Paul Lloyd
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 10
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 5
Davide Prandi
University of Trento
Career Start Year 2009
Number of shared co-authors 7
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 3
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 9
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 3
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 3
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 14
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 9
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 13
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 14
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 7
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 10
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 4
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 16
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Career Start Year 1997
Number of shared co-authors 15

Collaborators

Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 15
Kim N Chi
University of British Columbia
Co-authored papers 10
Matti Annala
University of British Columbia
Co-authored papers 10
Alexander W Wyatt
University of British Columbia
Co-authored papers 10
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 5
Martin E Gleave
University of British Columbia
Co-authored papers 5
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers 3
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 3
Elie Ritch
University of British Columbia
Co-authored papers 3
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Co-authored papers 3
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Cameron Herberts
University of British Columbia
Co-authored papers 3
Shaolong Cao
the University of Texas MD Anderson Cancer Center
Co-authored papers 2
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 2
Nikolai Engedal
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 2
Ladan Fazli
University of British Columbia
Co-authored papers 2
Dan J Woodcock
University of Oxford
Co-authored papers 2
Peter Van Loo
The Francis Crick Institute
Co-authored papers 2
Yuzhuo Wang
University of British Columbia
Co-authored papers 1
Shawna M Hubert
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 1
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 1
Xiao Zhao
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Jonas Demeulemeester
VIB-KU Leuven Center for Cancer Biology
Co-authored papers 1
Fred Saad
University of Montreal Health Center
Co-authored papers 1
Michael R Emmert-Buck
The Francis Crick Institute
Co-authored papers 1
Shuai Guo
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Bora Lim
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2